London, United Kingdom

Kanika Khurana

This inventor holds 2 USPTO granted patents. Top assignee: Chdi Foundation, Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kanika Khurana. Retrieved from https://idiyas.com/inventor/kanika-khurana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kanika Khurana: Innovator in Imaging Agents

Introduction

Kanika Khurana is a prominent inventor based in London, GB. She has made significant contributions to the field of imaging agents, particularly in relation to protein aggregation diseases. Her innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Kanika holds a patent for "Heterocyclic compounds and imaging agents for imaging huntingtin protein." This patent provides certain compounds and imaging agents that are useful for detecting diseases or conditions associated with protein aggregation. The compositions and methods outlined in her patent are vital for advancing medical imaging techniques.

Career Highlights

Kanika Khurana is currently associated with the Chdi Foundation, Inc., where she continues to work on groundbreaking research. Her dedication to innovation in the medical field has positioned her as a key figure in her area of expertise.

Collaborations

Throughout her career, Kanika has collaborated with notable colleagues, including Longbin Liu and Matthew Randolf Lee. These partnerships have enhanced her research and contributed to the success of her projects.

Conclusion

Kanika Khurana's work in developing imaging agents for protein aggregation diseases showcases her innovative spirit and commitment to advancing medical science. Her contributions are paving the way for improved diagnostic methods and better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…